Capital Performance Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,354
Closed -$269K 510
2025
Q4
$269K Buy
1,354
+225
+20% +$45.5K 0.02% 342
2025
Q3
$229K Buy
+1,129
New +$200K 0.04% 286
2024
Q4
Sell
-524
Closed -$87.1K 2435
2024
Q3
$87.1K Buy
+524
New +$79.2K 0.03% 231

Other funds holding THC

Capital Performance Advisors's THC Position: Q1 2026 in Review

Capital Performance Advisors sold out of Tenet Healthcare (THC) in Q1 2026, closing a stake of 1,354 shares — an estimated $269K sold.

Capital Performance Advisors first reported a position in THC in Q3 2024 and held it in 3 quarters. The position peaked at $269K in Q4 2025. 693 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Capital Performance Advisors reported no remaining Tenet Healthcare position as of Q1 2026 after selling out during the quarter.
  • Capital Performance Advisors sold 1,354 Tenet Healthcare shares in Q1 2026, an estimated $269K.
  • Capital Performance Advisors first reported a position in Tenet Healthcare in Q3 2024 and held it in 3 quarters.
  • Capital Performance Advisors's Tenet Healthcare position peaked at $269K in Q4 2025.
  • 693 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Capital Performance Advisors's 13F filing for Q1 2026, filed 7 May 2026.